Condition

Increased Iron Storage / Disturbed Distribution (1)

Myelodysplastic Syndrome (1)

Myelodysplastic Syndromes (1)

Myeloid Leukemia (1)

Non-alcoholic Steatohepatitis (1)

Porphyria Cutanea Tarda (1)

Thalassemia Major (1)

Overall Status

Completed (3)

Unknown status (2)

Phase

phase 2 (2)

phase 1/phase 2 (1)

phase 4 (1)

Sponsor

Assistance Publique - Hopitaux de Paris (1)

Crolll Gmbh (1)

DisperSol Technologies, LLC (1)

Hospices Civils de Lyon (1)

Wolfson Medical Center (1)

Collaborator

Association pour l'Etude des Fonctions Digestives (AEFD) (1)

Estimate, GmbH (1)

Hadassah Medical Organization (1)

Sheba Medical Center (1)

Soroka University Medical Center (1)

Tel-Aviv Sourasky Medical Center (1)

University of Magdeburg (1)

Intervention

exjade (5)

dst-0509 (1)

jadenu (1)

Study Documents

Intervention Type

drug (5)

Funder Type

Other (4)

Industry (1)

Study Type

Interventional (4)

Observational (1)

exjade

Showing 1 - 5 of 5

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

Completed

Thalassemia Major

DST-0509
+2 more

New York, New York
+3 more

Jan 31, 2022

Acute Myeloblastic Leukemia and Myelodysplastic Syndrome

Unknown status

Myeloid Leukemia
Myelodysplastic Syndromes

EXJADE

Pierre-Bénite, France

Centre Hospitalier Lyon Sud

Sep 3, 2018

Myelodysplastic Syndrome Trial in Holon (Exjade)

Completed

Myelodysplastic Syndrome

Exjade

Holon, Israel

Wolfsom Medical Center

Jun 13, 2014

Non-alcoholic Steatohepatitis, Increased Iron Storage / Disturbed Distribution Trial in Germany (Exjade)

Completed

Non-alcoholic Steatohepatitis
Increased Iron Storage / Disturbed Distribution

Exjade

Balingen/Hechingen, Germany
+8 more

Jul 19, 2012

Porphyria Cutanea Tarda Trial in Colombes (Exjade)

Unknown status

Porphyria Cutanea Tarda

Exjade

Colombes, Ile de France, France

Hopital Louis Mourier, GI unit,

Jan 26, 2011